ReviewKeynotepH-dependent ileocolonic drug delivery, part II: preclinical evaluation of novel drugs and novel excipients
Cited by (0)
Annemarie Broesder received her MSc in pharmacy from the University of Groningen (The Netherlands). Currently, she is pursuing her PhD in the Department of Pharmaceutical Technology and Biopharmacy at the University of Groningen under the supervision of Prof. Dr H.W. Frijlink and Dr. W.L.J. Hinrichs. Her research focuses on oral pH-dependent ileocolonic drug delivery and the suitability of these systems for different dosage forms.
Wouter L.J. Hinrichs studied chemistry at the University of Groningen and received his PhD from the University of Twente (The Netherlands) in 1993. Thereafter, he worked as a postdoc in the University of Twente and Utrecht University (The Netherlands) until 1998. Since then, he has been an assistant professor at the Department of Pharmaceutical Technology and Biopharmacy at Groningen Research Institute of Pharmacy (The Netherlands). One of his research interests is oral dosage forms. He has (co-)authored more than 140 original articles in peer-reviewed journals and book chapters.
Henderik W. Frijlink has been a professor and chairman of the Department of Pharmaceutical Technology and Biopharmacy at the Groningen Research Institute of Pharmacy since 1998. He is interested in solid oral dosage forms, their technological and biopharmaceutical aspects and gastrointestinal targeting strategy. Further interests of his current research are technical and biopharmaceutical aspects of pulmonary drug delivery. The formulation of biopharmaceuticals, such as peptides, proteins, vaccines, and gene-based products, using stabilizing sugar glasses is a further research topic in his department. He has published over 200 peer-reviewed papers in the field.